Agency Forms Undergoing Paperwork Reduction Act Review, 3737-3738 [2010-1167]

Download as PDF 3737 Federal Register / Vol. 75, No. 14 / Friday, January 22, 2010 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondents Type of forms Laboratorians .................................................. Nurses ............................................................. Doctors ............................................................ Form 32.1 ....................................................... Form 36.5 ....................................................... Form 36.5 ....................................................... Dated: January 18, 2010. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. 2010–1165 Filed 1–21–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–10–0222] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995. To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an e-mail to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project Questionnaire Design Research Laboratory (QDRL) 2010–2012, (OMB No. 0920–0222 exp. 2/28/2010)— Extension—National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC). Background and Brief Description Section 306 of the Public Health Service (PHS) Act (42 U.S.C. 242k), as amended, authorizes that the Secretary of Health and Human Services (DHHS), acting through NCHS, shall undertake and support (by grant or contract) research, demonstrations, and evaluations respecting new or improved methods for obtaining current data to support statistical and epidemiological activities for the purpose of improving the effectiveness, efficiency, and quality of health services in the United States. The Questionnaire Design Research Laboratory (QDRL) conducts questionnaire pre-testing and evaluation activities for CDC surveys (such as the NCHS National Health Interview Survey, OMB No. 0920–0214) and other federally sponsored surveys. NCHS is Number of responses per respondent 50,000 12,000 12,000 Average burden per response (in hours) 1 1 1 5/60 5/60 5/60 requesting 3 years approval of OMB for this extension. The QDRL conducts cognitive interviews, focus groups, mini fieldpretests, and experimental research in laboratory and field settings, both for applied questionnaire evaluation and more basic research on response errors in surveys. The most common questionnaire evaluation method is the cognitive interview. In a cognitive interview, a questionnaire design specialist interviews a volunteer participant. The interviewer administers the draft survey questions as written, but also probes the participant in depth about interpretations of questions, recall processes used to answer them, and adequacy of response categories to express answers, while noting points of confusion and errors in responding. Interviews are generally conducted in small rounds of 20–30 interviews. Similar methodology has been adopted by other federal agencies, as well as by academic and commercial survey organizations. There are no costs to respondents other than their time. The total estimated annualized burden hours are 625 hours. ESTIMATED ANNUALIZED BURDEN Number of respondents per year Respondents Test respondents ......................................................................................................................... Dated: January 15, 2010. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. 2010–1166 Filed 1–21–10; 8:45 am] erowe on DSK5CLS3C1PROD with NOTICES BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–10–0612] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the VerDate Nov<24>2008 14:43 Jan 21, 2010 Jkt 220001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 Number of responses per respondent 500 Average burden per response (in hours) 1 1.25 Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an e-mail to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project Well-Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) Reporting E:\FR\FM\22JAN1.SGM 22JAN1 3738 Federal Register / Vol. 75, No. 14 / Friday, January 22, 2010 / Notices System (OMB #0920–0612, exp. 1/31/ 2010)—Revision—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description Cardiovascular disease (CVD), which includes heart disease, myocardial infarction, and stroke, is the leading cause of death for women in the United States, and is largely preventable. The WISEWOMAN program (Well-Integrated Screening and Evaluation for Women Across the Nation), administered by the Centers for Disease Control and Prevention (CDC), was established to examine ways of improving the delivery of services for women who have limited access to health care and elevated risk factors for CVD. The program focuses on reducing CVD risk factors and provides screening services for select risk factors such as elevated blood cholesterol, hypertension and abnormal blood glucose levels. The program also provides lifestyle interventions and medical referrals. The WISEWOMAN program serves women who are participating in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), also administered by CDC. CDC requests OMB approval to continue collecting information from WISEWOMAN grantees for three years, with changes. There will be a net decrease in the total annualized burden hours. Although the number of funded grantees will increase from 15 to 21, the burden per respondent will decrease due to changes in the data collection plan and schedule. The collection of cost information will be discontinued and the Progress Report will be collected semi-annually instead of quarterly. Twice per year, each grantee will electronically transmit a Minimum Data Elements (MDE) dataset that contains information about the women served through the WISEWOMAN program, including their demographics, health status, CVD risk factors, referrals and participation in lifestyle interventions. In addition, each grantee will submit two written progress reports per year. The progress reports provide a narrative summary of grantee activities, as well as a discussion of each grantee’s progress toward meeting stated programmatic objectives. The information collected from grantees is used to assess the impact of the WISEWOMAN program. The overall program evaluation is designed to demonstrate how WISEWOMAN can obtain more complete health data on vulnerable populations, promote public education about disease incidence and risk-factors, improve the availability of screening and diagnostic services for under-served women, ensure the quality of services provided to under-served women, and develop strategies for improved interventions. There are no costs to respondents other than their time. The total estimated annualized burden hours are 1,680. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondent Form name WISEWOMAN Grantees ................................. Screening and Assessment MDEs ................ Intervention MDEs .......................................... Progress Report ............................................. Dated: January 15, 2010. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. 2010–1167 Filed 1–21–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0246] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishing and Maintaining a List of U.S. Dairy Product Manufacturers/Processors With Interest in Exporting to Chile erowe on DSK5CLS3C1PROD with NOTICES AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the VerDate Nov<24>2008 14:43 Jan 21, 2010 Jkt 220001 Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Fax written comments on the collection of information by February 22, 2010. ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202–395–7285, or e-mailed to oira_submission@omb.eop.gov. All comments should be identified with the OMB control number 0910–0509. Also include the FDA docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Denver Presley Jr., Office of Information Management (HFA–710), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–796–3793. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 21 21 21 Number of responses per respondent 2 2 2 Average burden per response (in hours) 16 8 16 Establishing and Maintaining a List of U.S. Dairy Product Manufacturers/ Processors With Interest in Exporting to Chile (OMB Control Number 0910– 0509)—Extension As a direct result of discussions that have been adjunct to the U.S./Chile Free Trade Agreement, Chile has recognized FDA as the competent U.S. food safety authority and has accepted the U.S. regulatory system for dairy inspections. Chile has concluded that it will not require individual inspections of U.S. firms by Chile as a prerequisite for trade, but will accept firms identified by FDA as eligible to export to Chile. Therefore, in the Federal Register of June 22, 2005 (70 FR 36190), FDA announced the availability of a revised guidance document entitled ‘‘Establishing and Maintaining a List of U.S. Dairy Product Manufacturers/ Processors With Interest in Exporting to Chile.’’ The guidance can be found at https://www.cfsan.fda.gov/ guidance.html. The guidance document explains that FDA has established a list that is provided to the government of Chile and posted on https:// E:\FR\FM\22JAN1.SGM 22JAN1

Agencies

[Federal Register Volume 75, Number 14 (Friday, January 22, 2010)]
[Notices]
[Pages 3737-3738]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-1167]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-10-0612]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-5806. 
Written comments should be received within 30 days of this notice.

Proposed Project

    Well-Integrated Screening and Evaluation for Women Across the 
Nation (WISEWOMAN) Reporting

[[Page 3738]]

System (OMB 0920-0612, exp. 1/31/2010)--Revision--National 
Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Cardiovascular disease (CVD), which includes heart disease, 
myocardial infarction, and stroke, is the leading cause of death for 
women in the United States, and is largely preventable. The WISEWOMAN 
program (Well-Integrated Screening and Evaluation for Women Across the 
Nation), administered by the Centers for Disease Control and Prevention 
(CDC), was established to examine ways of improving the delivery of 
services for women who have limited access to health care and elevated 
risk factors for CVD. The program focuses on reducing CVD risk factors 
and provides screening services for select risk factors such as 
elevated blood cholesterol, hypertension and abnormal blood glucose 
levels. The program also provides lifestyle interventions and medical 
referrals. The WISEWOMAN program serves women who are participating in 
the National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP), also administered by CDC.
    CDC requests OMB approval to continue collecting information from 
WISEWOMAN grantees for three years, with changes. There will be a net 
decrease in the total annualized burden hours. Although the number of 
funded grantees will increase from 15 to 21, the burden per respondent 
will decrease due to changes in the data collection plan and schedule. 
The collection of cost information will be discontinued and the 
Progress Report will be collected semi-annually instead of quarterly.
    Twice per year, each grantee will electronically transmit a Minimum 
Data Elements (MDE) dataset that contains information about the women 
served through the WISEWOMAN program, including their demographics, 
health status, CVD risk factors, referrals and participation in 
lifestyle interventions. In addition, each grantee will submit two 
written progress reports per year. The progress reports provide a 
narrative summary of grantee activities, as well as a discussion of 
each grantee's progress toward meeting stated programmatic objectives. 
The information collected from grantees is used to assess the impact of 
the WISEWOMAN program. The overall program evaluation is designed to 
demonstrate how WISEWOMAN can obtain more complete health data on 
vulnerable populations, promote public education about disease 
incidence and risk-factors, improve the availability of screening and 
diagnostic services for under-served women, ensure the quality of 
services provided to under-served women, and develop strategies for 
improved interventions.
    There are no costs to respondents other than their time. The total 
estimated annualized burden hours are 1,680.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondent                    Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
WISEWOMAN Grantees....................  Screening and Assessment              21               2              16
                                         MDEs.
                                        Intervention MDEs.......              21               2               8
                                        Progress Report.........              21               2              16
----------------------------------------------------------------------------------------------------------------


    Dated: January 15, 2010.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2010-1167 Filed 1-21-10; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.